|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00404716 |
|
Date of registration:
|
28/11/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation
|
|
Scientific title:
|
Effects of Triple Versus Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Undergoing Coronary Stent Implantation |
|
Date of first enrolment:
|
December 2004 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00404716 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Contacts
|
|
Name:
|
Yaling Han, Dr. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Shenyang Northern Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosed with ACS Undergoing coronary stent implantation
- Between ages of above 18 Years and bellow 80 Years.
- Presence of one or several stenosis in native coronary arteries requiring PCI.
- Willing and able to sign informed consent.
Exclusion Criteria:
- A history of bleeding diathesis.
- New York Heart Association functional class IV.
- Prior PCI or coronary bypass grafting < 3 months.
- Contraindications to clopidogrel and aspirin (White blood cells counts < 4×109/L or
platelet counts <100 g.l-1 ;creatinine clearance <25 ml • min-1 ;active liver
disease).
- Use of glycoprotein IIb/IIIa inhibitors before PCI.
- Preparing to undergo CABG
- Taken clopidogrel or cilostazol recently
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Coronary Syndrome
|
|
Intervention(s)
|
|
Drug: Cilostazol
|
|
Secondary ID(s)
|
|
NH-2006-A006
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|